Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Sargos

Showing results (11-20 of 180) with videos related to

Pageof 18
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 13, 2026
Optimizing prostate cancer stereotactic body radiotherapy: margins, dose, or target volume-de-intensification?Jennifer Le Guevelou, Paul Sargos, Thomas Zilli
Seminars in Radiation Oncology|June 14, 2025
Postoperative Radiation Therapy and Controversies Regarding Hormonal Therapy in the Management of Prostate CancerVérane Achard, Alan Dal Pra, Paul Sargos
European Urology Focus|October 27, 2024
Local Treatment (Primary Tumor and Metastases) in Metastatic Prostate CancerNicolas Benziane-Ouaritini, Alberto Bossi, Paul Sargos
Current Opinion in Supportive and Palliative Care|November 11, 2022
Radiation therapy post radical prostatectomy: who, when and why?Igor Latorzeff, Jennifer Le Guevelou, Paul Sargos
European Urology Oncology|February 18, 2026
Re: Riccardo Bertolo, Antonio Luigi Pastore, Paolo Verze, et al. Real-World Burden and Management of Late Genitourinary toxicity After Prostate Radiotherapy: Insights from IRRADIaTE, the Italian Registry of Radiotherapy-Associated Disorders and Urological Treatment & Evaluation. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2026.01.005Genevieve Loos, Paul Sargos, Olivier de Hertogh, et al.
JAMA Oncology|August 8, 2024
Hypofractionated Postprostatectomy Radiotherapy-Less is Really More?Nicolas Benziane-Ouaritini, Thomas Zilli, Paul Sargos
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|October 9, 2024
News and prospects on radiotherapy for bladder cancer: Is trimodal therapy becoming the gold standard?Olivier Riou, Christophe Hennequin, Jonathan Khalifa, et al.
International Journal of Radiation Oncology, Biology, Physics|August 4, 2021
Standard Versus Hypofractionated Radiation Therapy for Bladder Cancer: New Insights, but Questions RemainBrian C Baumann, Paul Sargos, Jason A Efstathiou
The Lancet. Oncology|November 27, 2025
SBRT in oligometastatic castration-resistant prostate cancerVérane Achard, Pierre Blanchard, David Pasquier, et al.
BJU International|April 5, 2019
Long-term androgen deprivation, with or without radiotherapy, in locally advanced prostate cancer: updated results from a phase III randomised trialPaul Sargos, Nicolas Mottet, Carine Bellera, et al.
Pageof 18

Showing results (11-20 of 180) with videos related to

Sort By:
Pageof 18
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 13, 2026
Optimizing prostate cancer stereotactic body radiotherapy: margins, dose, or target volume-de-intensification?Jennifer Le Guevelou, Paul Sargos, Thomas Zilli
Seminars in Radiation Oncology|June 14, 2025
Postoperative Radiation Therapy and Controversies Regarding Hormonal Therapy in the Management of Prostate CancerVérane Achard, Alan Dal Pra, Paul Sargos
European Urology Focus|October 27, 2024
Local Treatment (Primary Tumor and Metastases) in Metastatic Prostate CancerNicolas Benziane-Ouaritini, Alberto Bossi, Paul Sargos
Current Opinion in Supportive and Palliative Care|November 11, 2022
Radiation therapy post radical prostatectomy: who, when and why?Igor Latorzeff, Jennifer Le Guevelou, Paul Sargos
European Urology Oncology|February 18, 2026
Re: Riccardo Bertolo, Antonio Luigi Pastore, Paolo Verze, et al. Real-World Burden and Management of Late Genitourinary toxicity After Prostate Radiotherapy: Insights from IRRADIaTE, the Italian Registry of Radiotherapy-Associated Disorders and Urological Treatment & Evaluation. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2026.01.005Genevieve Loos, Paul Sargos, Olivier de Hertogh, et al.
JAMA Oncology|August 8, 2024
Hypofractionated Postprostatectomy Radiotherapy-Less is Really More?Nicolas Benziane-Ouaritini, Thomas Zilli, Paul Sargos
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|October 9, 2024
News and prospects on radiotherapy for bladder cancer: Is trimodal therapy becoming the gold standard?Olivier Riou, Christophe Hennequin, Jonathan Khalifa, et al.
International Journal of Radiation Oncology, Biology, Physics|August 4, 2021
Standard Versus Hypofractionated Radiation Therapy for Bladder Cancer: New Insights, but Questions RemainBrian C Baumann, Paul Sargos, Jason A Efstathiou
The Lancet. Oncology|November 27, 2025
SBRT in oligometastatic castration-resistant prostate cancerVérane Achard, Pierre Blanchard, David Pasquier, et al.
BJU International|April 5, 2019
Long-term androgen deprivation, with or without radiotherapy, in locally advanced prostate cancer: updated results from a phase III randomised trialPaul Sargos, Nicolas Mottet, Carine Bellera, et al.
Pageof 18